Objective: To describe the clinical presentation, outcome, and possible und
erlying mechanism of aqueous misdirection after glaucoma drainage device im
plantation.
Design: Retrospective, noncomparative, interventional case series.
Participants: Ten eyes (five primary open-angle glaucoma, four chronic angl
e-closure glaucoma, one nanophthalmos) of nine patients with a mean age of
68.5 +/- 12.0 years (range, 43-83 years).
Intervention: The authors reviewed the medical records of all patients with
a clinical diagnosis of aqueous misdirection after Baerveldt glaucoma drai
nage device implantation at two tertiary care referral centers from October
1992 to October 1997. Surgery was performed in a standardized fashion; all
drainage tubes were inserted in the anterior chamber and occluded with an
external 7-0 polyglactin ligature, All eyes were treated with topical corti
costeroids, cycloplegia, and aqueous suppressants. Eyes with persistent aqu
eous misdirection received neodymium:YAG (Nd:YAG) hyaloidotomy or pars plan
a vitrectomy.
Main Outcome Measures: Visual acuity, intraocular pressure, biomicroscopic
anterior chamber depth, and antiglaucomatous medication.
Results: All eyes had axial shallowing of the anterior chamber, one or more
patent iridotomies, and no ophthalmoscopic or B-scan ultrasonographic evid
ence of serous or hemorrhagic ciliochoroidal detachment. Median time to the
development of angle-closure glaucoma was 33.5 days (range, 1-343 days) an
d mean intraocular pressure at diagnosis was 27.7 +/- 18.7 mmHg (range, 10-
62 mmHg), Normalization of anterior segment anatomy was achieved with aqueo
us suppression and cycloplegia (one eye); Nd,YAG capsulotomy (four eyes); p
ars plana vitrectomy alone (two eyes) or with lensectomy (one eye), and par
s plana vitrectomy with intraocular lens explanation (two eyes). Mean final
intraocular pressure was 14.1 +/- 6.0 mmHg at a mean follow-up of 9.1 +/-
7.8 months after the development of aqueous misdirection (range, 1-23 month
s).
Conclusions: Aqueous misdirection may develop days to months after glaucoma
drainage device implantation. In this series, there was a poor response to
medical therapy, and normalization in anterior chamber depth required aggr
essive laser and surgical therapy.